Journal of Chest Surgery

The Korean Society for Thoracic and Cardiovascular Surgery (대한심장혈관흉부외과학회)
권호 표지
DOI QR코드

DOI QR Code

Current Status of Lung Cancer and Surgery Based on Studies Using a Nationwide Database

  • Kim, Dohun (Department of Thoracic and Cardiovascular Surgery, Chungbuk National University Hospital, Chungbuk National University College of Medicine) ;
  • Lee, Jung-Won (Department of Biochemistry, School of Medicine, Institute for Tumor Research, Chungbuk National University)
  • Received : 2021.09.10
  • Accepted : 2021.10.05
  • Published : 2022.02.05
Download PDF
⟨ Previous Next ⟩

Abstract

Lung cancer is a fatal disease, highlighting the importance of research on related topics, including surgery for lung cancer. However, systematic research analyzing surgery on a national scale is limited. This study aimed to investigate the research on lung cancer using nationwide data in South Korea and to analyze trends in lung cancer surgery, including its clinical implications. Published articles and data from the Korean National Health Insurance database were used. Although the incidence and mortality of lung cancer have been improving, it is predicted to be the most common and fatal type of cancer in South Korea in 2021. The number of surgical procedures for lung cancer is increasing, especially among women, those ≥76 years of age, residents of non-metropolitan cities, and middle-income patients. Lobectomy and sublobectomy, including segmentectomy, are increasingly common. However, the proportion of pneumonectomy relative to other procedures is not increasing. Surgery has shown a reasonable survival rate, especially after lobectomy, but survival remains poor in patients ≥76 years of age who undergo pneumonectomy. The frequency of lung cancer surgery is increasing concomitantly with various socioeconomic changes. Lobectomy has become increasingly common, and the clinical results of surgery are satisfactory. Further research on the changing composition of surgical candidates is required.

Keywords

Acknowledgement

This work was supported by the National Research Foundation of Korea (NRF) grant funded by the government of Korea (MSIP) (No., 2020R1F1A1060630).

References

  1. Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021;71:209-49. https://doi.org/10.3322/caac.21660
  2. Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. CA Cancer J Clin 2021;71:7-33. https://doi.org/10.3322/caac.21654
  3. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin 2020;70:7-30. https://doi.org/10.3322/caac.21590
  4. Hong S, Won YJ, Park YR, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2017. Cancer Res Treat 2020;52:335-50. https://doi.org/10.4143/crt.2020.206
  5. Jung KW, Won YJ, Hong S, Kong HJ, Im JS, Seo HG. Prediction of cancer incidence and mortality in Korea, 2021. Cancer Res Treat 2021;53:316-22. https://doi.org/10.4143/crt.2021.290
  6. Koshiaris C, Aveyard P, Oke J, et al. Smoking cessation and survival in lung, upper aero-digestive tract and bladder cancer: cohort study. Br J Cancer 2017;117:1224-32. https://doi.org/10.1038/bjc.2017.179
  7. de Koning HJ, van der Aalst CM, de Jong PA, et al. Reduced lungcancer mortality with volume CT screening in a randomized trial. N Engl J Med 2020;382:503-13. https://doi.org/10.1056/NEJMoa1911793
  8. Horn L, Mansfield AS, Szczesna A, et al. First-line atezolizumab plus chemotherapy in extensive-stage small-cell lung cancer. N Engl J Med 2018;379:2220-9. https://doi.org/10.1056/NEJMoa1809064
  9. Wu YL, Tsuboi M, He J, et al. Osimertinib in resected EGFR-mutated non-small-cell lung cancer. N Engl J Med 2020;383:1711-23. https://doi.org/10.1056/NEJMoa2027071
  10. Postmus PE, Kerr KM, Oudkerk M, et al. Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2017;28(suppl_4):iv1-21. https://doi.org/10.1093/annonc/mdx222
  11. Heo W, Kang DK, Min HK, Jun HJ, Hwang YH. Feasibility and safety of single-port video-assisted thoracic surgery for primary lung cancer. Korean J Thorac Cardiovasc Surg 2017;50:190-6. https://doi.org/10.5090/kjtcs.2017.50.3.190
  12. Lee JH, Hong JI, Kim HK. Robot-assisted thoracic surgery in non-small cell lung cancer. J Chest Surg 2021;54:266-78. https://doi.org/10.5090/jcs.21.070
  13. Lim TY, Park S, Kang CH. A meta-analysis comparing lobectomy versus segmentectomy in stage I non-small cell lung cancer. Korean J Thorac Cardiovasc Surg 2019;52:195-204. https://doi.org/10.5090/kjtcs.2019.52.4.195
  14. Brustugun OT, Gronberg BH, Fjellbirkeland L, et al. Substantial nation-wide improvement in lung cancer relative survival in Norway from 2000 to 2016. Lung Cancer 2018;122:138-45. https://doi.org/10.1016/j.lungcan.2018.06.003
  15. Schulkes K, Pouw C, Driessen E, et al. Lung cancer in the oldest old: a nation-wide study in the Netherlands. Lung 2017;195:627-34. https://doi.org/10.1007/s00408-017-0026-1
  16. Kim D, Kim SY, Suh B, Park JH. Trend analysis for the choice and cost of lung cancer treatment in South Korea, 2003-2013. Cancer Res Treat 2018;50:757-67. https://doi.org/10.4143/crt.2017.050
  17. Park S, Park IK, Kim ER, et al. Current trends of lung cancer surgery and demographic and social factors related to changes in the trends of lung cancer surgery: an analysis of the National Database from 2010 to 2014. Cancer Res Treat 2017;49:330-7. https://doi.org/10.4143/crt.2016.196
  18. Bernard A, Deschamps C, Allen MS, et al. Pneumonectomy for malignant disease: factors affecting early morbidity and mortality. J Thorac Cardiovasc Surg 2001;121:1076-82. https://doi.org/10.1067/mtc.2001.114350
  19. Tammemagi MC, Berg CD, Riley TL, Cunningham CR, Taylor KL. Impact of lung cancer screening results on smoking cessation. J Natl Cancer Inst 2014;106:dju084.
  20. Cao J, Yuan P, Wang Y, et al. Survival rates after lobectomy, segmentectomy, and wedge resection for non-small cell lung cancer. Ann Thorac Surg 2018;105:1483-91. https://doi.org/10.1016/j.athoracsur.2018.01.032
  21. Choi JS, Lee J, Moon YK, Moon SW, Park JK, Moon MH. Nodal outcomes of uniportal versus multiportal video-assisted thoracoscopic surgery for clinical stage I lung cancer. Korean J Thorac Cardiovasc Surg 2020;53:104-13. https://doi.org/10.5090/kjtcs.2020.53.3.104
  22. Jeon YJ, Choi YS, Lee KJ, Lee SH, Pyo H, Choi JY. Outcomes of pulmonary resection and mediastinal node dissection by video-assisted thoracoscopic surgery following neoadjuvant chemoradiation therapy for stage IIIA N2 non-small cell lung cancer. Korean J Thorac Cardiovasc Surg 2018;51:29-34. https://doi.org/10.5090/kjtcs.2018.51.1.29
  23. Kim HE, Yang YH, Lee CY. Video-assisted thoracic surgery segmentectomy. J Chest Surg 2021;54:246-52. https://doi.org/10.5090/jcs.21.058
  24. Marano A, Palagi S, Pellegrino L, Borghi F. Robotic intraoperative tracheobronchial repair during minimally invasive 3-stage esophagectomy. J Chest Surg 2021;54:154-7. https://doi.org/10.5090/jcs.20.055
  25. Song KS, Park CK, Kim JB. Efficacy of single-port video-assisted thoracoscopic surgery lobectomy compared with triple-port VATS by propensity score matching. Korean J Thorac Cardiovasc Surg 2017;50:339-45. https://doi.org/10.5090/kjtcs.2017.50.5.339
  26. Gonzalez-Aragoneses F, Moreno-Mata N, Simon-Adiego C, Penalver-Pascual R, Gonzalez-Casaurran G, Perea LA. Lung cancer surgery in the elderly. Crit Rev Oncol Hematol 2009;71:266-71. https://doi.org/10.1016/j.critrevonc.2008.09.010
  27. Palmer NR, Geiger AM, Lu L, Case LD, Weaver KE. Impact of rural residence on forgoing healthcare after cancer because of cost. Cancer Epidemiol Biomarkers Prev 2013;22:1668-76. https://doi.org/10.1158/1055-9965.EPI-13-0421